Study of the symptom improvement effect of gastric acid secretion inhibitors for refluxe esophagitis patients -Randomized controlled comparative test of vonoprazan and esomeprazole
Not Applicable
- Conditions
- Reflux esophagitis patients
- Registration Number
- JPRN-UMIN000028502
- Lead Sponsor
- ational Hospital Organization National Kochi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with a history of gastrointestinal resection or vagotomy. 2.Patients with confirmed or susupected malignant disease. 3.Pregnancy or lactation. 4.Past history of allergy for the drugs used in this therapy. 5.Ptients with sever liver dysfunction,sever renal dysfunction,sever hert dysfunction. 6.Ptients who are disqualifid for the study by physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Consideration of the symptom improvement value using the interview sheet after4,8 week treatment and the endoscopic improvement effect of after 8 week treatment
- Secondary Outcome Measures
Name Time Method The safety value of the treatment